Latest information on COVID-19


The Byers Eye Institute at Stanford University is dedicated to combating blindness and preserving sight. We deliver effective, integrated vision care across all specialties from one state-of-the-art, patient-centered facility in Palo Alto, California.


Our premier group of visionary scientists is leading innovations in diagnostics and the next generation of vision restorative therapeutics. Stanford's vision research faculty bring the latest in basic and translational research as well as clinical trials.


Residency training and clinical and research fellowships at Stanford in Retina, Glaucoma, Cornea, Oculoplastics, Pediatrics and Neuro-Ophthalmology, as well as special fellowships in international health and ophthalmic innovation, together offer exciting opportunities to advance the field and develop careers. 


Jeffrey L. Goldberg, M.D., Ph.D.
Professor and Chairman
Department of Ophthalmology

Welcome to the Byers Eye Institute in the Department of Ophthalmology, at Stanford University School of Medicine, a top-tier, internationally recognized, multidisciplinary center combining world-class resources with a commitment to providing the highest level of diagnostic and therapeutic care to our patients.

Through an integrated, personalized approach to healthcare delivery, our dedicated team provides the latest therapies in treating eye disorders. Associated with Stanford Health Care, and the Lucille-Packard Children's Hospital, our

Whether you are a patient, a resident, or a leader in academic or clinical ophthalmology, I invite you to explore our programs, visit our clinics and operating rooms, and receive your eye care from our premier faculty.

faculty and staff provide excellence in ocular and vision healthcare to patients across Northern California and from around the world, while our cutting-edge team of researchers carries out some of the most innovative laboratory research and clinical trials anywhere.

We are here for you.


We are searching for the best clinicians, clinician-scientists, and vision research scientists to join our faculty at Stanford. If you are looking for staff positions in administration or laboratory or clinical research, please follow this link.

In the News

DIYs at risk for increase in eye injuries during Coronavirus (COVID-19) sheltering-in-place

There are different ways to occupy your free time during COVID-19 stay home orders, but you should exercise extra caution before considering your next at-home do-it-yourself (DIY) project.

Rare eye disease is focus of new Stanford Medicine center

A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.

YOU'RE INVITED: Inaugural Optic Disc Drusen Virtual Conference

The Inaugural Optic Disc Drusen Virtual Conference will take place May 11, 2020 at Stanford via Zoom.

Applications are now open for the Ophthalmic Innovation Fellowship

Applications are now open and due no later than June 30, 2020 to be considered for the 2021-2022 academic year program.

Please prepare a CV and 1-page personal statement that includes goals for the year and career following the fellowship, and/or any questions via email to the Ophthalmic Innovation Program Fellowship, c/o Katie Majchrzak:

The Power List 2020 is here

Congratulations to these four faculty for being selected for The Ophthalmologist's Power List 2020, which celebrates the top 100 "most influential figures in ophthalmology"!

Updates on the Novel Coronavirus (COVID-19)

University and health system leaders are working closely with government and public health agencies and continue to follow guidelines from the U.S. Department of State, the Centers for Disease Control and Prevention, and the World Health Organization.

Introducing: the new Center for Optic Disc Drusen at Stanford

Optic disc drusen (ODD) are calcified deposits found at the anterior optic nerve in about 2% of the general population. It affects both children and adults and can sometimes run in families.

Hewlett Award Winner Mark S. Blumenkranz, MD, MMS: “I love what I do. It’s like a dream.”

The Albion Walter Hewlett Award is a Department of Medicine-sponsored award honoring an exceptional physician with ties to Stanford.

Direct-to-consumer genetic database used to identify AMD variants

CHICAGO — Researchers used a direct-to-consumer genetic testing service to identify patients with CFH Y402H and ARMS2 A69S alleles, the genetic variants most commonly associated with an increased risk for developing age-related macular degeneration, a speaker said here.

Invented at Stanford

The Stanford Department of Ophthalmology has a rich history of innovation and academic accomplishment dating back more than 100 years.

The gift of sight

Almost four years ago, Peggy Kixmoeller was diagnosed with thyroid eye disease (TED). This is an autoimmune disorder where the body mistakenly attacks healthy cells, specifically the thyroid gland and the tissues around the eye.

Stopping cancer in its tracks

To a passerby, Cru Silva looks like your average three-year-old. His energy is contagious as he runs around the room laughing and playing with his new toy garbage truck.

Going global

About 1.3 billion people worldwide live with some form of visual impairment, 80 percent of which could have been prevented or is treatable, according to the World Health Organization.

Photo courtesy of Ace Kvale and the Himalayan Cataract Project

SOAR Residency Program lays foundation for independent research careers

The Department of Ophthalmology at Stanford prides itself on training undergraduates, medical students, residents, and clinical fellows in both clinical care and innovative research.

One cell at a time

Retinal cell death due to glaucoma, diabetic retinopathy, macular degeneration, and a myriad of other conditions leads to irreversible vision loss.

Creating a field of molecular surgery to guide new therapies

A significant challenge for ophthalmologists is diagnosing diseases that appear clinically similar. Inside the eye, a “snowstorm” of white cells can be due to an autoimmune disease, cancer, or an infection, each requiring very different therapies.

Developing cures with stem cells and regenerative medicine

Too many major eye diseases lead to loss of vision that, even with current medicine or surgery, is irreversible. In macular degeneration, glaucoma, and the major corneal diseases, the cells responsible for normal visual function die and are not replaced through natural healing mechanisms.

SOAR resident receives grant from Knights Templar Eye Foundation to support retina research

Luciano Custo Greig, MD, PhD, a current trainee in the Stanford Ophthalmology Advanced Research (SOAR) Residency Program, is the recipient of a Career Starter Grant from the Knights Templar Eye Foundation for his research on regeneration of retinal ganglion cells from endogenous progenitors.

Mary M. and Sash A. Spencer Center for Vision Research established at Stanford

Philanthropic gift creates center to help accelerate translational research, recruit faculty and train the next generation of leaders in vision science.

The inaugural Stanford Ophthalmology 2019 Annual Report, "Vision Matters" highlights the department's recent news and accomplishments. Click here to read or download the PDF and click here to visit the Annual Report web page.

Illustration by Alton Szeto, MFA, © 2019.

The recent issue of Stanford Medicine magazine, a theme issue on eyes and vision, includes details about projects and others pushing the boundaries of biology and technology to help people see.  Click here to learn more

Illustration by John Hersey